Placing purines in precision medicine: Targeting a metabolic reliance in <i>KRAS</i>-mutant tumors. [PDF]
De Boni L +9 more
europepmc +1 more source
Targeted Protein Degradation of NUDT5 Dissociates Catalytic Inhibition from Protein Loss in 6-Thioguanine Response. [PDF]
Marques AMC +13 more
europepmc +1 more source
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update. [PDF]
Maillard M +18 more
europepmc +1 more source
Temporal transcriptomics identifies early-response and infection-condition-specific modules guiding host-directed anti-EBOV therapeutics. [PDF]
Zhang N +9 more
europepmc +1 more source
The association between 6-thioguanine nucleotide levels, adalimumab exposure, immune response, and drug clearance. [PDF]
Yarur A +4 more
europepmc +1 more source
The decline of 6-thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel disease. [PDF]
Bouwknegt DG +13 more
europepmc +1 more source
A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden. [PDF]
Secher CF +10 more
europepmc +1 more source
Severe Thiopurine-Induced Myelosuppression in a Pediatric Acute Lymphoblastic Leukemia Patient With the NUDT15 *1/*6 Genotype: A Brief Report. [PDF]
Fry J +10 more
europepmc +1 more source
Development and Validation of a Sensitive Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Simultaneous Quantification of Thiopurine Nucleotides in Human Red Blood Cells. [PDF]
Singh M, Kaushal S, Gupta K, Sood A.
europepmc +1 more source

